K213858: LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K213858 (LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus, cleared 2022-07-26 for DiaSorin, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K213858
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK213858
Cleared Device Trade / Generic NameLIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus
FDA Applicant on FilingDiaSorin, Inc.
FDA 3-Letter Product ClassificationProduct Code NXO
FDA Substantial Equivalence Decision Date2022-07-26
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at DiaSorin, Inc., compare peer devices under FDA Product Code NXO, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.